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Exposure of low-passage endothelial cells in culture to nonlethal amounts of asbestos, but not
refractory ceramic fiber-1, increases cell motility and gene expression. These changes may be
initiated by the fibers mimicking matrix proteins as ligands for receptors on the cell surface. In the
present study, 1- to 3-hr exposures of endothelial cells to 5 mg/cm2 of chrysotile asbestos caused
marked cell elongation and motility. However, little morphological change was seen when
chrysotile was added to cells pretreated with either mannosamine to prevent assembly of
glycophosphatidylinositol (GPI)-anchored receptors or with herbimycin A to inhibit tyrosine kinase
activity. Affinity purification of GPI-anchored urokinase-type plasminogen activator receptor
(uPAR) from chrysotile-exposed cells demonstrated that asbestos altered the profile of proteins
and phosphoproteins complexed with this receptor. Tyrosine kinase activities in the complexes
were also increased by asbestos. Immunoprecipitations with selective monoclonal antibodies
demonstrated that both chrysotile and crocidolite asbestos increase kinase activities associated
with p60 Src or p120 focal adhesion kinase (FAK). Further, chrysotile also changed the profile of
proteins and phosphoproteins associated with FAK in intact cells. These data suggest that
asbestos initiates endothelial cell phenotypic change through interactions with uPAR-containing
complexes and that this change is mediated through tyrosine kinase cascades.- Environ Health
Perspect 105(Suppl 5):1131-1137 (1997)
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Introduction
Inhalation of asbestos fibers is a major
health risk causing pulmonary fibrosis
(asbestosis), mesotheliomas, and lung
carcinomas (1-3). Hallmarks ofasbestosis
include increased fibrinolysis (4), expansion
of interstitial matrix components (5), and
angiogenesis (6). These events are indica-
tive of activated pulmonary cells, which
require enhanced pericellular proteolytic
activity and matrix interactions for cell
motility and proliferation (7-9). Many
studies have examined the pathogenesis of
pneumoconiosis related to asbestos or other
fibers, yet few have investigated cellular and
molecular mechanisms for activation ofvas-
cular cells contacted by fibers (3,5).
Inhaled chrysotile asbestos fibers
accumulate along capillaries and penetrate
into the capillary lumen (3,10). Asbestos
increases the permeability ofthe pulmonary
endothelium, the proliferative rates of
endothelial cells (6,10), and the synthesis
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ofproteins associated with wound repair or
fibrosis (11-13). Several weeks after a sin-
gle 1-hr exposure to chrysotile asbestos,
aberrant pulmonary endothelial and smooth
muscle cell proliferation occurs in the small
arterioles and venules of animals (10).
Recent studies using cultured cells demon-
strated that noncytotoxic concentrations of
asbestos, but not refractory ceramic fiber-1
(RCF-1), induce an activated endothelial
cell phenotype (14). This phenotype is
elongated, has increased motility, and
increased expression ofadhesion molecules
for phagocytes (14).
Vascular remodeling and activated
endothelial cells are associated with increased
proteolytic cascades, which are initiated by
activation of urokinase-type plasminogen
activator (uPA). uPA activity is elevated in
many physiological settings requiring vas-
cular cell motility and proliferation, such as
ovulation, angiogenesis, tumor metastasis,
and smooth muscle or monocyte migration
in atherosclerosis (8). Expression of uPA
receptor (uPAR) is also increased in remod-
eling and can be induced by cytokines, hor-
mones, and tumor promoters (8,9). The
binding of uPA to uPAR is central to the
role ofendothelial cells in tissue remodel-
ing and is essential for endothelial cell
motility (8,15-17). The effects of uPA on
cell morphology, motility, and prolifera-
tion require receptor occupancy, but often
not uPA proteolytic activity (18-20).
uPAR is a glycophosphatidylinositol
(GPI)-anchored surface receptor that local-
izes either to insoluble lipid-protein com-
plexes(21,22) on the cell surface or to focal
adhesions attached to matrix-bound
vitronectin (23,24). Addition of the gly-
coinositol phospholipid to the carboxyl tail
ofuPAR allows targeting and insertion into
the outer cell membrane. GPI-anchored
receptors have no transmembrane domain
but transduce signals through soluble
kinases associated with the inner mem-
brane leaflet through N-terminal lipid
modifications(22,25-28). Both tyrosine
(22,27) and serine/threonine kinases (28)
complex with GPI-anchored receptors to
mediate their responses. Further, uPARcom-
plexes with integrin-containing signaling
complexes (22) and can regulate integrin
function (29).
Endothelial cells responding to asbestos
elongate and move around the fibers (14).
Direct activation of endothelial cells by
asbestos could be explained by the fibers
mimicking ligands, such as fibronectin or
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vitronectin, which bind cell surface
proteins (30,31). Boylan et al. (31)
demonstrated that pleural mesothelial cells
internalize vitronectin or serum-coated cro-
cidolite asbestos fibers via an avb5 integrin-
dependent mechanism. However, the
affinity ofvitronectin for uPAR is higher
than its affinity for integrins (24). As dis-
cussed above, activation ofuPAR promotes
endothelial cell motility and deformability
(17). Therefore, the role ofuPAR in initi-
ating cell signaling linked to morphological
and phenotypical change was examined in
second- to fourth-passage porcine aortic or
human microvascular endothelial cells. The
data obtained demonstrate that asbestos
requires both GPI-anchored receptors and
tyrosine phosphorylation to elicit morpho-
logical change. Chrysotile asbestos alters
the profiles of proteins complexed with
uPAR and activates tyrosine kinases in
these complexes. Chrysotile and crocidolite
asbestos, but not RCF-1, activate endothe-
lial cell tyrosine kinases. These studies sug-
gest that activation of uPAR-signaling
complexes and tyrosine-kinase cascades
provides an axis for induction of gene
expression and phenotypic change in
response to asbestos.
Materials and Methods
Materials. Culture media, balanced salts
solutions, culture supplements, GRGDSP
peptide, and trypsin were from Life
Technologies (Gaithersburg, MD).
Characterized fetal bovine serum (FBS) was
from Hyclone Laboratories (Logan, UT).
[35S]methionine (Expre35S35, 1000
Ci/mmol) and [32P]orthophosphate (9000
Ci/mmol) were from Dupont/NewEngland
Nuclear (Boston, MA). Growth factors,
protease inhibitors, and mannosamine were
from Sigma (St. Louis, MO). All other
reagents were ofthe highest purityavailable.
Cell Culture. Porcine endothelial cells
were enzymatically isolated from fresh
aortas as previously described (32). Third
passage human pulmonary microvascular
endothelial cells were obtained from
Clonetics Corporation (San Diego, CA).
Both cell types were cultured to confluence
in 0.1% gelatin-coated 25 cm2 flasks con-
taining the defined endothelial cell medium
(33): MCDB 131 media containing 10
ng/ml human epidermal growth factor, 1.0
pg/mi hydrocortisone, and 5% FBS. The
cultures were maintained at 37°C under an
atmosphere of5% CO2/ 95% air and post-
confluent monolayers were used in all
experiments. Greater than 95% ofthe cells
tested positive for endothelial cell-specific
markers such as antigenicity for antifactor
VIII antibody and for rapid uptake ofDi-I
acetylated LDL (32). The culture medium
was replaced 18 hr prior to the beginning
of an experiment and fiber additions were
made in the presence or absence ofserum
as indicated.
Fiber Samples. Reference samples of
National Institute ofEnvironmental Health
Sciences chrysotile and crocidolite asbestos
used in these studies were obtained from
B. Mossman (University of Vermont,
Burlington, VT). All fibers were greater
than 10 p. Working preparations offibers
were baked at 200°C for 12 hr to remove
endotoxin or other biological contami-
nants. The fibers were then diluted in ster-
ile Dulbecco's modified Eagle's medium
(DMEM) and tested for endotoxin using
the E-toxate assay (Sigma).
Metabolic Labeling ofIntact Cells.
Confluent cells were metabolically labeled
with [32P]orthophosphate as previously
described (34,35). Briefly, cells were rinsed
in low phosphate MEM and then incu-
bated in the same buffer with 0.1 mCi/ml
ofcarrier-free [32P]orthophosphate for 1 hr
at 37°C, under 5% C02/95% air. Asbestos
was then added for up to 1 hr, and expo-
sures were stopped by rinsing the cells twice
with cold stop buffer (10 mM Tris-HCl,
pH 7.4, 10 mM EDTA, 5 mM EGTA,
100 mM NaF, 200 mM sucrose, 100 pM
Na-orthovanadate, 5 mM pyrophosphate,
4 pg/ml leupeptin, 4 pg/ml soybean trypsin
inhibitor, 1 mM benzamidine, 20 pM
calpain inhibitor 1, 100 mU/ml aprotinin,
and 100 pM phenylmethylsulfonyl fluo-
ride). The cells were then lysed at room
temperature in 10 mM Tris-HCI, pH 8.0,
2 mM EDTA, 0.2 M sucrose, 0.14 M
NaCl, 1.0 mM orthovanadate, 2.5 mM
MgCl2, and protease inhibitors. Samples
were then immediately added to uPA-coated
plates as described below.
Cells in 35-mmwells were metabolically
labeled with [35S]methionine. They were
rinsed with serum-free, methionine/cys-
teine-deficient DMEM. One milliliter of
the same media containing 0.1 mCi/ml
[35S]methionine was then added. After
2 hr, an additional milliter of complete
DMEM containing 10% serum was added.
Eighteen hours later, cells were exposed to
asbestos as described above. Samples were
collected and prepared as described for
those labeledwith [32P]orthophosphate.
Solid-phase Affinity Platesfor uPAR.
The methods described by Busso et al. (28)
for uPAR signaling in human epithelial
cells and by Bohuslav et al. (22) for uPAR
signaling in monocytes were used with
slight modification. Microtiter wells were
coated for 2 hr with 50 pl of 50 pg/ml of
recombinant pro-uPAR (a gift from J.
Henkin, Abbott Laboratories, Abbott Park,
IL) in phosphate-buffered saline (PBS).
The wells were rinsed three times with 100
pl of PBS containing 1% bovine serum
albumin (BSA) and then incubated with
200 p1 ofthe same buffer for an additional
2 hr. The wells were then rinsed with cell
lysis buffer and 100 pl of cell lysate was
added to each well. To control for non-spe-
cific absorption, aliquots oflysates were also
added to wells coated with PBS plus 1%
BSA, but no pro-uPAR. The lysates were
incubated overnight at 40C with gende agi-
tation. They were then rinsed 3 times with
200 pl oflysis buffer and then twice with
kinase buffer. The samples were then either
used for in vitro kinase assays or collected
for electrophoresis by addition of 50 pil of
electrophoresis buffer, transfer to a fresh
storage tube, and then boiling for 5 min.
Immunoprecipitations. Immuno-
precipitations were performed as previously
described (35). Briefly, following asbestos
exposure, cells were lysed in cold RIPA
buffer (35) and centrifuged to remove
debris. Supernates were incubated overnight
at 40C with specific antibody and protein A
Sepharose beads (Pharmacia, Piscataway,
NJ) coated with rabbit antimouse IgG (200
pg ofantibody/ml ofbeads). The complexes
were rinsed 3 times with RIPA buffer and
twice with kinase buffer. Kinase assays were
performed immediately to preserve activity.
KinaseAssays. Tyrosine kinase activity
of proteins purified with microtiter affin-
ity plates or by immunoprecipitation were
performed essentially as described (35 ).
Kinase buffer (45 pl; 20 mM Hepes, pH
7.5; 5 mM MnCl2, 5 mM MgCl2, and
0.1 mM orthovanadate) was added to pel-
lets of immunobeads or to microtiter
wells. The kinase reactions were initiated
by adding 5 pl of 32PyATP (5 pCi, 10
pM) and were incubated at 220C for 20
min. Incubations with immunobeads were
stopped by placing on ice, centrifuging at
13,000xgand 4°C for 30 sec, and replac-
ing the kinase buffer with 50 pl of elec-
trophoresis buffer. All samples were boiled
for 5 min and separated by polyacry-
lamide gel electrophoresis (PAGE). Gels
were stained with Coomassie Blue to assure
equal protein recoveries and autoradio-
graphs were prepared for comparison of
incorporated 32P04. These reaction condi-
tions favor autophosphorylation and sub-
strate phosphorylations by tyrosine kinases.
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Figure 1. Morphological change in response to asbestos. Postconfluent endothelial cells were incubated v
medium alone or media containing inhibitors for varying periods of time before addition of 5 pg/cm2 of chrysc
asbestos to half of the cultures for 3 hr. The cultures were then photographed without fixing. Mannosamine
mM) was added for 6 hr before asbestos exposure. Herbimycin A (1 pM) was added for 18 hr before asbeq
exposure. GRGDSP peptide (100 pg/ml) was added for 1 hr before asbestos exposure. An F is placed below sc
of the large fibers or fiber bundles in the field. The cells in the photographs are representative of those in at IE
five microscopic fields.
Results and Discussion
; Inhibition ofGPI-Assembly or
Tyrosine KinaseActivityPrevents
Asbestos-induced Changes
inMorphology
Nonlethal levels ofasbestos, but not RCF-
i1 fibers, cause marked changes in the
morphology and phenotype ofendothelial
cells (14). As shown in Figure 1B, the
m normal endothelial cell monolayer is dis-
rupted by a 3-hr exposure to chrysotile
asbestos as the cells move over and around
B the fibers. The elongation ofthe cells can
1 be oberved as early as 2 hr after addition
of chrysotile and is sustained beyond
72 hr (the longest time point examined).
No overt toxicity is observed during these
prolonged exposures (14).
Re-alignment of the cells along the
fibers implies that matrix contacts have
been altered. Asbestos engages integrins on
; mesothelial cells (31) and changes in inte-
grin signaling could mediate the motility of
tmz the endothelial cells in Figure 1. However,
D addition of a saturating amount of syn-
thetic RGD-containing peptide (100
gg/ml), which is known to block integrin
binding (30,31), did not prevent asbestos-
s induced endothelial cell elongation (Figure
i6- 1G,H). uPA and uPAR are also central to
t cell adhesion and motility in various cell
i types (18,20,24), including endothelial
cells (17). In addition to binding uPA and
facilitating its activation, uPAR regulates
fI-integrin function (29) and serves as a
r high-affinity binding site for vitronectin
(24). Therefore, the role of uPAR in
F asbestos-induced changes in endothelial
cell shape was examined in control and
mannosamine-treated cells. Mannosamine
prevents assembly of the GPI anchor and
g thereby insertion of uPAR and other GPI-
anchored proteins into the plasma mem-
brane (24,36). The data in Figure 1C,D
indicate that a 6-hr mannosamine treat-
ment causes a slight increase in vacuoles,
but has little effect on endothelial cell
> shape. However, endothelial cells treated
with mannosamine prior to addition of
asbestos were resistant to asbestos-induced
H shape change. The fact that chrysotile
fibers are still attached to these cells indi-
cates that GPI-anchored proteins mediate
vith morphological change in response to
)tile asbestos, but additional proteins or lipids
!(10 facilitate fiber binding. This is similar to
stos previous results demonstrating that vit-
ome ronectin is required for integrin-dependent
east internalization of crocidolite, but not for
adherence ofcrocidolite to cells (31).
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Both integrins and GPI-anchored
proteins signal through the Src-family of
tyrosine kinases (22,37,38). Therefore,
herbimycin A, a relatively selective
inhibitor of Src-related kinases (39), was
used to determine whether these kinases
are required for morphologic change in
response to chrysotile fibers. Eighteen- to
twenty-four-hour treatment with her-
bimycin A causes some loosening ofcon-
tacts between endothelial cells (Figure 1
E,F). However, herbimycin A-treated cells
did not elongate in response to asbestos.
Again, the chrysotile fibers still attached to
these cells. This suggests that the mecha-
nisms for fiber binding are proximal to or
independent from signals involved in
morphologic change.
AsbestosActivates uPAR
SignalingComplexes
uPAR associates with signaling complexes
in specialized regions ofthe cell membrane
(22,28). Therefore, cells were metaboli-
cally labeled with [35S]methionine to
examine whether chrysotile asbestos affects
the composition of proteins complexed
with uPAR. After exposing the cells to
chrysotile fibers, lysates were prepared and
aliquots were affinity purified in microtiter
wells coated with pro-uPA. Nonadherent
proteins were rinsed away; adherent pro-
teins were lysed from the wells and then
separated by PAGE. Data presented in
Figure 2A demonstrate that asbestos causes
proteins to complex with uPAR. The mass
ofseveral proteins in the complex, espe-
cially those with apparent molecular
weights of 116, 60, 42.7, and 38 kDa,
increase relative to the mass of a 66-kDa
protein. Synthesis of new proteins would
be limited at these early time points, which
suggests that asbestos mobilizes proteins in
the cells.
Protein interactions or mobilization
is facilitated by changes in their phos-
phorylation state. Cells were labeled with
[32p]orthophosphate to examine the effect of
asbestos on the phosphorylation state of
proteins complexed with uPAR. Figure 2
shows that chrysotile increases the phospho-
rylation ofmany proteins in the complex,
most notably a 36-kDa protein and proteins
with molecular weights greater than 97
kDa. The effect is transient but illustrates
that there are many proteins oflow abun-
dance that become hyperphosphorylated.
Also, asbestos changes the stoichiometry of
the phosphoproteins in the complex. The
most pronounced examples ofthis are the
38- and 60-kDa proteins. The increase in
MW
kDa '
212
158
116
97.2
64.4
55.6 *..
42.7 "
36.5
26.6
35s
A
kDa
212-
116-
66-
55.6 -
42.7 -
t5 60
Time, min
pro-uPA BSA
0 15 30 45 60 0 15
B
Figure 2. Changes in uPAR-associated signaling complexes after exposure to asbestos. (A) The cells were labeled
with either [35S]methionine or [32P]orthophosphate for 18 hr as described in "Materials and Methods." Chrysotile
asbestos (5 pg/cm2) was added for the times given and then cells were lysed. Lysates were incubated in pro-uPA
coated affinity plates and adherent proteins were separated by 8% PAGE. The gel was stained with Coomassie
Brillant Blue and then autoradiographed. The data are a composite of the Coomassie Brillant Blue image of the
molecularweight markers combined with an image of the autoradiograph. (B) Nonlabeled cells were exposed to 5
pg/cm2 of chrysotile for up to 60 min and then lysates were prepared and purified in microtiter wells coated with
pro-uPA or BSA. Kinase assays were then performed and the resulting phosphoproteins were separated by PAGE.
These data represent three separate experiments.
the phosphorylation state of these proteins
precedes significant increases in their mass
in the complex (35S bands compared to 32p
bands in Figure 2A). The increased phos-
phorylation may serve as a recognition sig-
nal for the proteins. However, other signals
must be required for dissolution ofthe com-
plexes, since the increased mass ofthe pro-
teins in the complex is sustained longer than
the increases in phosphorylation.
Asbestos Increases KinaseActivities
in uPARComplex
The data in Figure 2A indicate that the
content ofphosphoproteins in uPAR com-
plexes is increased by asbestos. Therefore,
in vitro kinase assays in the microtitre wells
were used to study whether asbestos acti-
vates kinases complexed with membrane-
bound uPAR. Lysates were prepared from
intact cells exposed to asbestos for up to 60
min. The lysates were incubated in micro-
titer wells coated with pro-uPA or with the
BSA- blocking solution alone. The wells
were rinsed and kinase reactions were con-
ducted in situ. The autoradiograph ofthe
resulting phosphoproteins is shown in
Figure 2B and illustrates that asbestos
causes time-dependent increases in the
phosphorylation ofseveral bands. The den-
sity of bands at 212, 98, and 60 kDa
reached maximal intensity by 30 min. The
strong intensity ofa 48-kDa band did not
peak until 45 min, indicating that asbestos
differentially activates multiple kinases or
kinase cascades in the intact cells. The
specificity of the assay is demonstrated by
the lack ofkinase activity in the BSA wells.
The differences between the phosphoryla-
tion profiles in Figure 2A,B illustrates the
limitations ofthe two analyses. uPAR and
integrin signaling are highly dependent on
the context ofthe intact cell and its matrix
attachments. The in vitro kinase assays
demonstrate that substrate phosphoryla-
tion by kinases is activated by asbestos, but
do not provide much information regard-
ing the substrates that become phosphory-
lated in the intact cell. Also, phosphatase
activity is inhibited in the in vitro assay,
which allows more phosphorylated sub-
strates to accumulate. However, the data in
Figures 1 and 2 demonstrate that adding
asbestos to intact endothelial cells initiates
uPAR-associated signaling cascades that
precede cell elongation.
AsbestosInreasesTyrosine
KinaseActvitiesAssociated
with SrcandFAK
The data in Figure 1E,F indicate that Src-
related kinases mediate asbestos-induced
shape changes. Further, Src associates
with FAK complexed with integrins (38).
Therefore, in vitro kinase assays using
endothelial cell immunoprecipitates were
used to determine whether asbestos activates
Src or FAK. RIPA lysates were prepared
from control cells or cells exposed to
equally nontoxic concentrations ofchryso-
tile or crocidolite asbestos for 15 min. The
samples were split into two aliquots and
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immunoprecipitated with monodonal anti-
body recognizing either to Src (clone 327,
Oncogene Science, Uniondale, NY) or to
FAK (done 2A7, obtained from T. Parsons,
University ofVirginia, Charlottesville, VA).
The immunobead/antigen complexes were
assayed for kinase activity and the autoradi-
ographs ofthe resulting phosphoproteins
are shown in Figure 3A. Both types of
asbestos induced formation ofa doublet of
57- to 60-kDa phosphoproteins in the Src
immunoprecipitates and ofa similar band
immunoprecipitating with FAK. There is
no increased phosphorylation ofa 120-kDa
protein, which is the expected molecular
weight of FAK. This indicates that auto-
phosphorylation ofFAK is not increased by
asbestos. However, asbestos does appear to
either increase substrate phosphorylation by
FAK or to increase the activity ofa kinase
co-precipitating with FAK. Autophos-
phorylation ofan Src-related kinase brought
into association with FAK in response to
asbestos would explain the appearance of
the 57- to 60-kDa band. However, further
experiments will be required to identify
this phosphoprotein.
AsbestsAlters theProfile ofProteins
Co-preipitaingwithFAK
FAK is found in large intracellular
signaling complexes at sites ofintegrin con-
tacts with the extracellular matrix (38).
Therefore, cells were metabolically labeled
with [35S]methionine and then exposed to
chrysotile to determine whether asbestos
alters the composition ofthese complexes.
The autoradiograph in Figure 3B presents
the profile of[35S]-labeled proteins immuno-
precipitated from control and asbestos-
exposed cells with monoclonal antibody to
FAK. Exposure to chrysotile results in a
profound change in the protein profile by
15 min. There is loss ofproteins in many
regions of the autoradiograph. However,
there is a significant gain in a 60-kDa
band. This suggests that asbestos induces a
dissolution offocal contacts and changes
the proteins associated with FAK.
Increased phosphorylation of focal
adhesion proteins disrupts cytoskeletal
elements and facilitates cell elongation
(40,41). Therefore, cells labeled with
[32P]ortho-phosphate were exposed to
chrysotile to determine whether asbestos
increases phosphorylation ofFAK-associated
proteins in the intact cell. Immunopre-
cipitates ofcontrol and chrysotile-exposed
cells demonstrate increased phosphorylation
ofmany proteins after 30 min ofexposure
to the fibers, including a pronounced band
at 60 kDa (Figure 3C). The increases in the
60-kDa band relative to the 116- and 50-
kDa bands indicate that asbestos increases
their phosphorylation state but not the
distribution of ATP pools or cellular
phosphate incorporation.
Endothelial cells from different organs
and species are heterogeneous in their
responses. Therefore, chrysotile-induced
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phosphorylations were examined in
[32P]orthophosphate-labeled human pul-
monary microvascular endothelial cells. The
experimental paradigm was identical to the
studies in Figure 3C, except that the lysates
were split into two aliquots. The first aliquot
was immunoprecipitated with mAb 2A7 and
the second with a monoclonal antibody to
phosphotyrosine (clone pY69, Santa Cruz
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Figure 3. Tyrosine phosphorylation and changes in signaling proteins complexed with FAK. (A) Lysate were pre-
pared from control cells or cells exposed to either 10 pg/cm2 of chrysotile or 5 pg/cm2 of crocidolite asbestos for
15 min. The lysates were immunoprecipitated with monoclonal antibodies recognizing either Src (mAb 327) or FAK
(mAb 2A7). Kinase assays were performed using these precipitates and the resulting phosphoproteins were sepa-
rated by PAGE and detected by autoradiography. (B) [35S]Methionine-labeled cells were exposed to chrysotile (5
pg/cm2), lysed in the lysis buffer for uPAR extraction, and then separated by PAGE. The composite image is of the
Coomassie Brillant Blue-stained molecularweight markers and the autoradiograph ofthe dried gel. (C) Porcine aor-
tic cells were labeled for 1 hrwith[32P]orthophosphate before adding buffer or chrysotile (5 pg/cm2). Lysates were
prepared in RIPA buffer and immunoprecipitated with mAb 2A7. The proteins were separated by PAGE, stained
with Coomassie Brillant Blue, and then detected by autoradiography of dried gels. 3D: Human microvascular
endothelial cells were labeled with [32Pjorthophosphate as in Figure 3C and exposed to chrysotile (5 pg/cm2). RIPA
lysates were prepared and immunoprecipitated with either mAb 327 or pY69, which recognize phosphotyrosine.
The precipitated proteins were separated by PAGE and detected by autoradiography. All experiments were
performed intriplicate.
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Biotechnology, Santa Cruz, CA). The pro-
teins in the immunoprecipitates were sepa-
rated on 8% polyacrylamide gels and
phosphoproteins are shown in the autoradi-
ography in Figure 3D. As observed in the
porcine aortic cells, treatment ofthe human
microvascular cells with 5 pg/cm2 of
chrysotile asbestos resulted in time-depen-
dent increases in phosphorylation of60- and
212-kDa proteins co-precipitating with FAK
(Figure 3D) relative to a 116-kDa band.
Increases were also observed in the pY69
immunoprecipitates, which suggests that the
proteins become hyperphosphorylated on
tyrosine residues.
Conclusion
These data support the hypothesis that sub-
lethal amounts ofasbestos initiate motility
changes through activation ofuPAR- and
integrin-associated signaling cascades.
Elongation of the cells in response to
chrysotile asbestos is greatly reduced by
preventing insertion of uPAR into the
plasma membrane or by inhibiting tyrosine
kinase signaling cascades. Asbestos increases
the association of proteins with uPAR
signaling complexes. However, at the same
time, asbestos causes dissolution of pro-
teins associated with FAK. Asbestos acti-
vates p6O Src and perhaps other Src-related
kinases, which may mediate the changes in
uPAR and FAK protein complexes. More
investigations will be required for the iden-
tification ofthe proteins that are altered in
response to asbestos and the relationships
ofthese alterations to facilitating endothe-
lial cell activation and motility in response
to asbestos.
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